Age-related macular degeneration (AMD) is the leading cause of blindness among older adults. The exudative or ‘wet’ form of the disease is characterized by the growth of abnormal blood vessels from ...

Variant, a company dedicated to developing innovative treatments for orphan inherited eye diseases, and the Rare Ocular Diseases Center at the University ofCampania Luigi Vanvitelli ...

Pathologically, AMD is characterized by degeneration of retinal pigment epithelium (RPE) and/or fluid accumulation in the subretinal space. [5] The RPE supports photoreceptors and is separated ...

OpRegen is delivered as a suspension to the subretinal space in a onetime surgical procedure and it's currently in a Phase 2a study called the GAlette Study that's being managed by our partners ...

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2024 Earnings Call Transcript March 10, 2025 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

The ophthalmological presentation is variable, and there may be hemorrhage from the subretinal space to the vitreous cavity, with the most frequent presentations being vitreous or pre-retinal ...

So I think the other aspect is this is a massive multi billion dollar space. So are all patients going to be amenable to subretinal administration? No. But our investigators and also thought leaders ...